3Prof. Dr. H. Knothe,PD Dr. P. Shah,Dr. V. Krcmery,Dr. M. Antal,Prof. Dr. S. Mitsuhashi. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens[J] 1983,Infection(6):315～317 被引量：1
4M. T. Nüesch-Inderbinen,H. H?chler,F. H. Kayser. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test[J] 1996,European Journal of Clinical Microbiology & Infectious Diseases(5):398～402 被引量：1
5A. Philippon,G. Arlet,P. H. Lagrange. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases[J] 1994,European Journal of Clinical Microbiology & Infectious Diseases(1):S17～S29 被引量：1
4Clinical and Laboratory Standards Institute. M100-S21 Performance standards for antimicrobial susceptibility testing; Twenty-first information supplement. Wayne PA, 2011. 被引量：1
